Insulet Stock Falls After Dexcom Denies Buyout Talks
marketwatch.com
news
2022-05-31 14:16:00

By Will Feuer Shares of Insulet Corp. fell more than 11% in early trading after Dexcom Inc., a designer of continuous glucose monitoring systems, denied news reports that it is in talks to buy Insulet. Dexcom said Tuesday that it "is not in active discussions regarding a merger transaction at this time." Insulet shares fell more than 11% to $208.27 in the morning. The stock is down almost 22% so far this year. Shares of Dexcom rose more than 7% Tuesday morning to $310.12. That stock is still down more than 42% so far this year.
